- Home
- TEVA vs EXPE Comparison
TEVA vs EXPE Comparison
Compare TEVA & EXPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEVA
- EXPE
- Stock Information
- Founded
- TEVA 1901
- EXPE 1996
- Country
- TEVA Israel
- EXPE United States
- Employees
- TEVA N/A
- EXPE N/A
- Industry
- TEVA Biotechnology: Pharmaceutical Preparations
- EXPE Transportation Services
- Sector
- TEVA Health Care
- EXPE Consumer Discretionary
- Exchange
- TEVA Nasdaq
- EXPE Nasdaq
- Market Cap
- TEVA 21.2B
- EXPE 26.7B
- IPO Year
- TEVA N/A
- EXPE 1999
- Fundamental
- Price
- TEVA $25.79
- EXPE $276.43
- Analyst Decision
- TEVA Strong Buy
- EXPE Buy
- Analyst Count
- TEVA 7
- EXPE 29
- Target Price
- TEVA $25.86
- EXPE $247.04
- AVG Volume (30 Days)
- TEVA 12.8M
- EXPE 2.2M
- Earning Date
- TEVA 11-05-2025
- EXPE 11-06-2025
- Dividend Yield
- TEVA N/A
- EXPE 0.58%
- EPS Growth
- TEVA N/A
- EXPE 35.97
- EPS
- TEVA 0.62
- EXPE 10.37
- Revenue
- TEVA $16,776,000,000.00
- EXPE $14,370,000,000.00
- Revenue This Year
- TEVA $4.11
- EXPE $6.73
- Revenue Next Year
- TEVA $0.40
- EXPE $6.36
- P/E Ratio
- TEVA $40.72
- EXPE $26.38
- Revenue Growth
- TEVA 0.02
- EXPE 7.29
- 52 Week Low
- TEVA $12.47
- EXPE $130.01
- 52 Week High
- TEVA $25.88
- EXPE $277.06
- Technical
- Relative Strength Index (RSI)
- TEVA 81.89
- EXPE 77.29
- Support Level
- TEVA $23.61
- EXPE $208.44
- Resistance Level
- TEVA $25.00
- EXPE $270.22
- Average True Range (ATR)
- TEVA 0.79
- EXPE 8.38
- MACD
- TEVA 0.56
- EXPE 6.17
- Stochastic Oscillator
- TEVA 98.93
- EXPE 98.50
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About EXPE Expedia Group Inc.
Expedia is the world's second-largest online travel agency by bookings, offering services for lodging (80% of total 2024 sales), air tickets (3%), rental cars, cruises, in-destination, and other (10%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, but its three core online travel agency brands are Expedia, Hotels.com, and Vrbo. It also has a metasearch brand, Trivago. Transaction fees for online bookings account for the bulk of sales and profits.